PROSION with new publication in the Proceedings of the National Academy of Sciences of the U.S.A.

Designed nanomolar small-molecule inhibitors of Ena/VASP EVH1 interaction impair invasion and extravasation of breast cancer cells

PROSION Blog Cover - Publication In the PNAS

Designed nanomolar small-molecule inhibitors of Ena/VASP EVH1 interaction impair invasion and extravasation of breast cancer cells.

Access the publication with the following link: https://www.pnas.org/content/117/47/29684

PROSION receives an EIC Grant of €2.5m

The European Commission backs PROSION with a 2.5 million grant through their prestigious EIC Accelerator, with the option for PROSION to receive additional funding through an equity investment. The EIC accelerator supports individual small and medium enterprises (SMEs) to develop and scaleup game-changing innovations. Following a highly-competitive application process, the selected companies are offered a combination

READ MORE
Scroll to Top